Please ensure Javascript is enabled for purposes of website accessibility
Divisive FDA Vaccine Regulator Resigns
d8a347b41db1ddee634e2d67d08798c102ef09ac
By The New York Times
Published 24 minutes ago on
March 7, 2026

An undated photo provided by the U.S. Food and Drug Administration shows Dr. Vinay Prasad, the agency’s chief science and medical officer. Prasad is leaving the agency at the end of April, a spokesman for Health and Human Services said. (U.S. Food and Drug Administration via The New York Times)

Share

Getting your Trinity Audio player ready...

Dr. Vinay Prasad, a polarizing figure at the Food and Drug Administration who oversaw vaccines, is leaving the agency at the end of April, according to a Health and Human Services spokesperson.

As the agency’s chief science and medical officer, Prasad had broad power over vaccines. He made several controversial decisions, including overruling career scientists on some vaccine approvals and cracking down on a biotech company tied to patient harm.

Last summer, he was dismissed after right-wing influencer Laura Loomer led an attack against him. At the insistence of Dr. Marty Makary, the agency’s commissioner, and Health Secretary Robert F. Kennedy Jr., he was soon brought back.

The Wall Street Journal first reported his departure.

In recent weeks, Prasad drew criticism for rejecting medications intended to treat rare diseases. He also made headlines when he refused to accept Moderna’s application for a new mRNA flu vaccine, a decision Makary soon reversed.

Before joining the agency, Prasad was an academic at the University of California, San Francisco. He was known for criticizing the FDA, saying its drug review officials had a low bar for approval.

He has also been described as a COVID contrarian, after complaining on podcasts and on his YouTube channel about public health measures that he deemed ill-informed by medical evidence.

According to a senior administration official, Prasad was on leave for a year from his job in California and had planned to return.

This article originally appeared in The New York Times.

By Christina Jewett

c.2026 The New York Times Company

RELATED TOPICS:

Search

Keep the news you rely on coming. Support our work today.

Send this to a friend